Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Renata Rcc Bonadio

9PUBLICATIONS

62CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Mar 06, 2026

Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).

Leandro Jonata de Carvalho Oliveira, Daniella Castro Araújo, Júlio Antonio Pereira de Araújo

|May 16, 2025

Unveiling the paradigm shift: systemic treatment strategies in small, node-negative breast cancer.

Mariana Carvalho Gouveia, Mariana Scaranti, Bruna Migliavacca Zucchetti

|Dec 17, 2024

Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Patients With Hormone Receptor-Positive Advanced Breast Cancer.

Lis Victoria Ravani, Pedro Calomeni, Maysa Vilbert

|Aug 14, 2024

Dose dense versus 3 weekly AC during neoadjuvant chemoimmunotherapy for triple negative breast cancer.

Renata Colombo Bonadio, Isadora Martins de Sousa, Flávia Cavalcanti Balint

|Jul 11, 2024

Unplanned Hospital Admissions in Patients With Solid Tumors in Brazil: Causes and Progressive Disease's Impact on Outcomes.

Cassio Murilo Hidalgo Filho, Felippe Lazar Neto, Vitor Pinheiro Sobottka

|Oct 13, 2021

Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy.

Laura Testa, Max Mano, Roberto Jun Arai

Pageof 2

Frequent Collaborators

4 joint publications

Laura Testa

3 joint publications

Romualdo Barroso-Sousa

3 joint publications

Paulo M Hoff

2 joint publications

Jose Bines

2 joint publications

Max Senna Mano

1 joint publications

Maria Fernanda Batistuzzo Vicentini Neffa

1 joint publications

Elizabeth Zambrano Mendoza

1 joint publications

Letícia Leone Lauricella

1 joint publications

Teresa Yae Takagaki

1 joint publications

Ricardo Mingarini Terra

Frequent Collaborators

4 joint publications

Laura Testa

3 joint publications

Romualdo Barroso-Sousa

3 joint publications

Paulo M Hoff

2 joint publications

Jose Bines

Top Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on : May 09, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on : Mar 20, 2020

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on : May 09, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on : Mar 20, 2020

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos